Supply chain will be first to face blockchain disruption, says GlobalData

4 July 2018
blockchain_network_big

The first applications of blockchain in healthcare will emerge in the supply chain, says GlobalData.

According to the data and analytics company, action taken by Merck & Co (NYSE: MRK) is evidence of where this much-feted new technology will start to appear in the drug industry.

"Although in the long term blockchain will revolutionize many aspects of healthcare on the patient level, the first applications will emerge in the supply chain, which is less resistant to change"

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical